| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $2.66 (Beat by $0.24) |
| EPS GAAP Actual | $2.66 (Beat by $0.24) |
| Revenue Actual | $0.580624B |
| Revenue Surprise | Beat by $580.624M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2028 | 7.14 | 20.25 | 6.88974 | 7.35181 | 3 |
| Mar 2028 | 7.14 | 20.25 | 6.87274 | 7.32008 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.75 | 2.75 | 0.580624B | 4.29% | 580.62M |
| FQ3 2025 (Sep 2025) | 2.57 | 2.57 | 0.56096B | 3.41% | 560.96M |
| FQ2 2025 (Jun 2025) | 1.1734 | 1.1734 | 0.407272B | 8.16% | 407.27M |
| FQ1 2025 (Mar 2025) | 1.35 | 1.35 | 0.424456B | 12.4% | 424.46M |
| FQ4 2024 (Dec 2024) | 2.19 | 2.19 | 0.555738B | -11.38% | 555.74M |
| FQ3 2024 (Sep 2024) | 1.92 | 1.92 | 0.541857B | 11.22% | 541.86M |
| FQ2 2024 (Jun 2024) | 0.79 | 0.79 | 0.374026B | 15.24% | 374.03M |
| FQ1 2024 (Mar 2024) | 0.83 | 0.83 | 0.371827B | -0.27% | 371.83M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1.71 | -- | 1.65297 | 1.76464 | 1 |
| FQ4 2027 (Dec 2027) | 3.15 | -- | 3.04495 | 3.25066 | 1 |
| FQ3 2027 (Sep 2027) | 2.55 | -- | 2.46496 | 2.63149 | 1 |
| FQ2 2027 (Jun 2027) | 1.37 | -- | 1.32431 | 1.41378 | 1 |
| FQ1 2027 (Mar 2027) | 1.47 | -- | 1.4692 | 1.47163 | 1 |
| FQ4 2026 (Dec 2026) | 2.73357 | -0.6 | 2.64241 | 2.82092 | 1 |
| FQ3 2026 (Sep 2026) | 2.35 | -9.36 | 2.34872 | 2.35261 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.44B | -- | 0.43B | 0.45B | 2 |
| FQ4 2027 (Dec 2027) | 0.61B | -- | 0.6B | 0.63B | 3 |
| FQ3 2027 (Sep 2027) | 0.54B | -- | 0.53B | 0.56B | 3 |
| FQ2 2027 (Jun 2027) | 0.4B | -- | 0.39B | 0.41B | 3 |
| FQ1 2027 (Mar 2027) | 0.45B | -- | 0.45B | 0.45B | 3 |
| FQ4 2026 (Dec 2026) | 0.59B | 1.76 | 0.58B | 0.61B | 3 |
| FQ3 2026 (Sep 2026) | 0.55B | -1.56 | 0.55B | 0.55B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.75 | 2.75 | 100% | |
| FQ3 2025 (Sep 2025) | 2.57 | 2.57 | 100% | |
| FQ2 2025 (Jun 2025) | 1.1734 | 1.1734 | 100% | |
| FQ1 2025 (Mar 2025) | 1.35 | 1.35 | 100% | |
| FQ4 2024 (Dec 2024) | 2.19 | 2.19 | 100% | |
| FQ3 2024 (Sep 2024) | 1.92 | 1.92 | 100% | |
| FQ2 2024 (Jun 2024) | 0.79 | 0.79 | 100% | |
| FQ1 2024 (Mar 2024) | 0.83 | 0.83 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $0.58B | $580.62M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $0.56B | $560.96M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.41B | $407.27M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.42B | $424.46M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.56B | $555.74M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.54B | $541.86M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.37B | $374.03M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.37B | $371.83M | 100% |